Post-marketing surveillance of pirfenidone for idiopathic pulmonary fibrosis in Japan: Interim analysis of 973 patients

被引：0
|
作者：
Ito, Maki [1 ]
Niimi, Yuka [1 ]
Nakamura, Akihiro [1 ]
Kakutani, Shinichi [2 ]
Yoshida, Yuki [2 ]
Yoshikawa, Takayoshi [1 ]
机构：
[1] Shionogi & Co Ltd, Drug Safety Management Dept, Osaka, Japan
[2] Shionogi & Co Ltd, Biostat Dept, Osaka, Japan
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
Idiopathic pulmonary fibrosis; Interstitial lung disease;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2087
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Acute exacerbation of idiopathic pulmonary fibrosis: Analysis in a post-marketing surveillance of pirfenidone
    Taniguchi, Hiroyuki
    Azuma, Arata
    Ogura, Takashi
    Inoue, Yoshikazu
    Chida, Kingo
    Bando, Masashi
    Kakutani, Shinichi
    Inagaki, Shuichiro
    Suga, Moritaka
    Sugiyama, Yukihiko
    Kudoh, Shoji
    Nukiwa, Toshihiro
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [2] All-case post-marketing surveillance of 1371 patients treated with pirfenidone for idiopathic pulmonary fibrosis
    Ogura, Takashi
    Azuma, Arata
    Inoue, Yoshikazu
    Taniguchi, Hiroyuki
    Chida, Kingo
    Bando, Masashi
    Niimi, Yuka
    Kakutani, Shinichi
    Suga, Moritaka
    Sugiyama, Yukihiko
    Kudoh, Shoji
    Nukiwa, Toshihiro
    [J]. RESPIRATORY INVESTIGATION, 2015, 53 (05) : 232 - 241
  • [3] Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan
    Takashi Ogura
    Yoshikazu Inoue
    Arata Azuma
    Sakae Homma
    Yasuhiro Kondoh
    Katsumi Tanaka
    Kaori Ochiai
    Yukihiko Sugiyama
    Toshihiro Nukiwa
    [J]. Advances in Therapy, 2023, 40 (4) : 1474 - 1493
  • [4] Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan
    Ogura, Takashi
    Inoue, Yoshikazu
    Azuma, Arata
    Homma, Sakae
    Kondoh, Yasuhiro
    Tanaka, Katsumi
    Ochiai, Kaori
    Sugiyama, Yukihiko
    Nukiwa, Toshihiro
    [J]. ADVANCES IN THERAPY, 2023, 40 (04) : 1474 - 1493
  • [5] Safety and Efficacy of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis: A Nationwide Post-Marketing Surveillance Study in Korean Patients
    Man Pyo Chung
    Moo Suk Park
    In Jae Oh
    Heung Bum Lee
    Young Whan Kim
    Jong Sun Park
    Soo Taek Uh
    Yun Seong Kim
    Yangjin Jegal
    Jin Woo Song
    [J]. Advances in Therapy, 2020, 37 : 2303 - 2316
  • [6] Safety and Efficacy of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis: A Nationwide Post-Marketing Surveillance Study in Korean Patients
    Chung, Man Pyo
    Park, Moo Suk
    Oh, In Jae
    Lee, Heung Bum
    Kim, Young Whan
    Park, Jong Sun
    Uh, Soo Taek
    Kim, Yun Seong
    Jegal, Yangjin
    Song, Jin Woo
    [J]. ADVANCES IN THERAPY, 2020, 37 (05) : 2303 - 2316
  • [7] Interim analysis of post-marketing surveillance of omalizumab in Japan
    Ohta, Ken
    Yoshisue, Hajime
    Aoki, Yasuo
    Irokawa, Takuro
    Ishigaki, Masahide
    Adachi, Mitsuru
    Miyamoto, Terumasa
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [8] All-case post-marketing surveillance (PMS) of pirfenidone in Japan: Clinical characteristics, efficacy and safety profile in >1300 patients with idiopathic pulmonary fibrosis (IPF)
    Inoue, Yoshikazu
    Azuma, Arata
    Ogura, Takashi
    Taniguchi, Hiroyuki
    Chida, Kingo
    Bando, Masashi
    Niimi, Yuka
    Kakutani, Shinichi
    Suga, Moritaka
    Sugiyama, Yukihiko
    Kudoh, Shoji
    Nukiwa, Toshihiro
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [9] A NATIONWIDE POST-MARKETING STUDY INVESTIGATING SAETY AND EFFICACY OF PIRFENIDONE IN KOREAN PATIENTS WITH ADVANCED IDIOPATHIC PULMONARY FIBROSIS
    Song, Jin Woo
    Chung, Man Pyo
    Park, Moo Suk
    Oh, In Jae
    Lee, Heung Bum
    Kim, Young Whan
    Park, Jong Sun
    Uh, Soo Taek
    Kim, Yun Seong
    Jegal, Yang Jin
    [J]. RESPIROLOGY, 2019, 24 : 85 - 86
  • [10] Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan
    Ninomiya, Haruhiko
    Obara, Naoshi
    Chiba, Shigeru
    Usuki, Kensuke
    Nishiwaki, Kaichi
    Matsumura, Itaru
    Shichishima, Tsutomu
    Okamoto, Shinichiro
    Nishimura, Jun-ichi
    Ohyashiki, Kazuma
    Nakao, Shinji
    Ando, Kiyoshi
    Kanda, Yoshinobu
    Kawaguchi, Tatsuya
    Nakakuma, Hideki
    Harada, Daisuke
    Akiyama, Hirozumi
    Kinoshita, Taroh
    Ozawa, Keiya
    Omine, Mitsuhiro
    Kanakura, Yuzuru
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 104 (05) : 548 - 558
12345